Kezar Life Sciences Inc (KZR)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | John Fowler |
Employees: | 60 |
Web site: | kezarlifesciences.com |
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
650-822-5600
|
Date | Ratio |
---|---|
2024-10-30 | 1:10 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Kezar Life Sciences, Inc. engages in the discovery and development of novel small molecule therapeutics. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis.
Please log in first to see chart